| abstract |
The present disclosure relates to 5, 5-bisubstituted-2-iminopyrrolidine derivatives, preparation processes and pharmaceutical compositions containing them. Specifically, the present disclosure relates to novel 5, 5-bisubstituted-2-iminopyrrolidine derivatives presented by formula (I), the uses for treatment especially for thrombin receptor antagonists, in which each substitute group of general formula (I) is as defined in the specification. |